Skip to main content
4DMEDICAL LIMITED logo

4DMEDICAL LIMITED — Investor Relations & Filings

Ticker · 4DX ISIN · AU0000095416 LEI · 9845000A8F12A6A6FD75 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 546 across all filing types
Latest filing 2023-05-07 Regulatory Filings
Country AU Australia
Listing ASX 4DX

About 4DMEDICAL LIMITED

https://4dmedical.com/

4DMedical Limited develops non-invasive respiratory imaging solutions centered on its proprietary XV Technology. This platform utilizes advanced algorithms to transform standard X-ray sequences into four-dimensional quantitative data, visualizing regional lung function in motion. The flagship XV Lung Ventilation Analysis Software (XV LVAS) provides clinicians with detailed maps of airflow distribution throughout the respiratory cycle, facilitating the early detection and monitoring of chronic conditions such as COPD, asthma, and interstitial lung disease. By providing objective, high-resolution insights into lung ventilation without the limitations of traditional pulmonary function tests, the company's cloud-based diagnostic tools aim to improve clinical workflows and patient management. The integration of artificial intelligence further enhances its capability to deliver precise, automated lung tissue analysis.

Recent filings

Filing Released Lang Actions
4DMedical Investor Webinar Details 2 pages 176.7KB
Regulatory Filings Classification · 90% confidence The document is an ASX announcement inviting shareholders and investors to an upcoming investor webinar hosted by the CEO. The content focuses on the webinar details, topics to be discussed (capital raise, commercialization, milestones), registration instructions, and contact information. There is no substantive financial data, report content, or detailed analysis presented. The document is short (3012 characters) and serves as an announcement for an event rather than a report or transcript. Therefore, it fits best as an Investor Presentation (IP) announcement or a Regulatory Filing (RNS). However, since it is an announcement of a webinar (presentation) rather than the presentation itself, and given the lack of detailed financial or strategic content, the best fit is Regulatory Filings (RNS) as a general announcement category for miscellaneous filings that do not fit other categories.
2023-05-07 English
4DMedical wins commercial pilot with US Dept of Defense 2 pages 210.6KB
Capital/Financing Update Classification · 90% confidence The document is an ASX announcement dated 05 May 2023, describing a commercial pilot contract won by 4DMedical with the U.S. Department of Defense. It focuses on a business development milestone and commercial arrangement rather than financial results, management changes, or regulatory filings. The content is a corporate announcement about a commercial contract, not a financial report, earnings release, or regulatory filing. The document length is 3672 characters, which is relatively short and consistent with an announcement rather than a detailed report. Therefore, the most appropriate classification is Capital/Financing Update (CAP), as it relates to a commercial contract and business development update.
2023-05-04 English
Application for quotation of securities - 4DX 10 pages 36.4KB
Share Issue/Capital Change Classification · 95% confidence The document is an application for quotation of securities issued under an employee incentive scheme by 4DMedical Limited. It details the number and type of securities to be quoted, issue dates, prices, and compliance with ASX Listing Rules. There is no financial performance data, earnings information, or management discussion. The document is a regulatory announcement related to capital market activities, specifically the quotation of new securities. This fits the category of Share Issue/Capital Change (SHA) as it concerns new securities being quoted on the exchange.
2023-05-04 English
Pause in Trading 1 page 119.0KB
Regulatory Filings Classification · 100% confidence The document is a brief market release announcing a pause in trading of the company's securities. It is very short (341 characters) and does not contain any financial data, report content, or detailed information. It is an official regulatory announcement related to trading status, not a financial report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-05-03 English
Trading Halt 3 pages 275.3KB
Regulatory Filings Classification · 95% confidence The document is a market announcement from 4DMedical Limited regarding a trading halt requested pending an upcoming announcement about a proposed capital raising and a new material commercial arrangement. It is a short notice primarily about the trading halt and does not contain financial statements, detailed financial data, or the actual announcement of the capital raising or commercial arrangement. The document is under 5,000 characters and serves as a regulatory announcement related to trading status rather than a full report or detailed update. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other specific categories.
2023-05-03 English
4DMedical conducts first commercial scan within VA 3 pages 250.1KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 01 May 2023 from 4DMedical Limited about the first commercial scan within the Veterans Health Administration (VA). It discusses the company's commercial activity, strategic engagements, and future plans related to their respiratory imaging technology. There are no financial statements, quarterly or annual results, nor any regulatory filings or voting results. The content is a corporate announcement about a commercial milestone and strategic progress, not a financial report, audit, or management change. It fits best as a general regulatory announcement about company progress and commercial activity, which aligns with the Regulatory Filings (RNS) category.
2023-04-30 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.